Nevirapine ER Coupons & Discount Card – Guaranteed Prices from $75.53

Nevirapine, known as Viramune, is associated with several serious safety risks and requires careful monitoring. Below are key safety warnings and precautions to consider before and during the treatment:

• Liver Problems: Nevirapine can cause severe liver damage, potentially leading to liver failure or the need for a transplant. The risk is particularly high within the first four months of treatment. Individuals, especially women with higher T-cell counts, and those with a history of liver problems or hepatitis B or C, face increased risk. Regular blood tests are necessary to monitor liver function, and those with moderate to severe liver issues should not use nevirapine. If symptoms such as persistent nausea, loss of appetite, yellowing skin/eyes, or dark urine occur, seek medical assistance immediately.

• Severe Skin and Allergic Reactions: Serious skin and allergic reactions can occur, some of which may be life-threatening. These are most likely to manifest within the first six weeks of treatment. Women are at higher risk. It is crucial to start with a lower dose to assess tolerance. If symptoms like rash, fever, mouth sores, or facial swelling appear, discontinue use and contact a healthcare provider right away.

• Overactive Immune System: Nevirapine, when used in combination with other HIV medications, can lead to an overactive immune response known as immune reconstitution syndrome. This condition may cause the immune system to attack healthy cells. Symptoms such as fever, pain, or hair loss should be reported to a healthcare provider immediately.

• Changes in Body Fat: Some individuals on HIV medications, including nevirapine, might experience changes in body fat distribution. These changes include fat accumulation in specific areas like the neck and abdomen or fat loss from the limbs and face. Report any such changes to your healthcare provider.

• Drug Interactions: Certain medications can alter how nevirapine is metabolized, impacting its effectiveness and increasing side effects. Discuss any other drugs you are taking with your healthcare provider.

• Contraindications: Nevirapine is not recommended for individuals with moderate to severe liver problems or for post-exposure prophylaxis (PEP) treatment.

In case of an overdose or severe reaction, seek emergency medical help immediately. Always inform your healthcare providers about any adverse reactions you have experienced with nevirapine in the past. Regular medical and lab appointments are essential to ensure the safety and effectiveness of the treatment.

Common side effects:

• tiredness
• nausea
• vomiting
• diarrhea
• mild rashes

Less common but important to monitor:

• drowsiness
• headaches
• belly pain
• muscle aches
• changes in body fat distribution

Serious side effects:

• severe allergic reactions
• liver injury
• overactive immune system

Interactions with high risk of serious adverse effects and should be avoided:

• prednisone
• hormonal birth control methods (such as pills, patches, rings)

Interactions with moderate risk that may require dose adjustment, closer monitoring, or timing changes:

• orlistat
• rifabutin
• warfarin
• rifamycins (such as rifampin)
• St. John's wort
• antiarrhythmics (such as amiodarone)
• atazanavir
• cobicistat
• elvitegravir
• seizure medications (such as clonazepam)
• azole antifungals (such as itraconazole, ketoconazole)
• macrolide antibiotics (such as clarithromycin)
• methadone